• Localization of GFP-HMGB1 to DNA damage induced by laser micro-irradiation

  • Co-localization of novel RSR protein with RPA


David S. Yu, M.D., Ph.D.
Assistant Professor
Department of Radiation Oncology
Emory University School of Medicine
Georgia Research Alliance Cancer Scientist
Winship Cancer Institute
Building C, Room 3008
1365 Clifton Road NE
Atlanta, GA 30322

404-778-1758 (office)
404-778-5520 (fax)
404-778-2193 (lab)


Dr. David Yu recently received the Michael Fry Award from the Radiation Research Society on Sept. 22 during an award lecture. The Michael Fry Award was established to recognize junior scientists who have made extraordinary contributions to the field of radiation research.

Congratulations to Scott Smith for his first-author publication in Nucleic Acids Research on identification of NEK9 as a novel replication stress response protein.

Congratulations to Elaine Liu who will be enrolling in the MSTP program at the University of Michigan Medical School.

Congratulations to Lauren Colbert for her first-author publication in Cancer Research Journal on how CHD7 is a novel DNA damage response protein whose expression predicts survival outcomes in patients with resected pancreatic cancer. Lauren also received a RSNA Medical Student Research Grant and an Emory Radiation Oncology Medical Students Scholars Award to complete this work.  

Congratulations to Bill Hall for his first-author publication in Oncogene on how low CHD5 expression activates the DNA damage response and predicts for poor outcome in patients with early-stage resected pancreatic cancer. Dr. Hall also received first place for his presentation of this work on Resident Research Day.

Congratulations to Hui Zhang for her first-author publication in PNAS on how SIRT2 directs the replication stress response through CDK9 deacetylation. Dr. Zhang gave an oral presentation of this work at the RRS annual meeting in New Orleans.

Our Research

Dr. Yu is an Assistant Professor in the Department of Radiation Oncology at Emory University School of Medicine. He received his MD from the University of Texas at Southwestern Medical School and PhD from the University of Cambridge prior to completing residency training in Radiation Oncology at Vanderbilt University Medical Center. He graduated with honors from Stanford University with a BS in Biology.

Dr. Yu is a Georgia Cancer Coalition Distinguished Cancer Clinician and Scientist. He is currently funded by a NIH/NCI R01, a NIH/NCI K08, a University Research Council Pilot Award, and a Georgia Cancer Coalition Distinguished Cancer Scholar Award. Dr. Yu has authored a number of publications in high impact journals, including Nature, Cell, Molecular Cell, EMBO, and PNAS. During his residency training, Dr. Yu was an American Board of Radiology (ABR) Holman Research Pathway fellow. He received the American Society for Radiation Oncology (ASTRO) Resident Clinical/Basic Science Research Award and Radiologic Society of North America (RSNA) Roentgen Resident/Fellow Research Award.

Dr. Yu is a member of the ASTRO Radiation and Cancer Biology Committee Research Council, ASTRO Research Evaluation Committee Research Council, American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), Radiation Research Society (RRS), and RSNA among others. He is also a member of the Winship Cancer Institute Cancer Genetics and Epigenetics (CGE) Progam, Emory Graduate Program in Cancer Biology (CB), and Graduate Program in Genetics and Molecular Biology (GMB).

In his free time, Dr. Yu enjoys running, gardening, traveling, cooking, and spending time with his family.